InnovHeart
Company

Last deal

$55M

Amount

Series C

Stage

27.01.2022

Date

2

all rounds

$73M

Total amount

General

About Company
InnovHeart develops Transcatheter Mitral Valve Replacement systems.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2015

Number of employees

Last funding type

Series C

IPO status

Private

Description

InnovHeart is a company with locations in Milan, Italy, and Boston, Massachusetts, that focuses on developing Transcatheter Mitral Valve Replacement systems (TMVR) to treat patients suffering from mitral valve disease. Their novel Saturn TMVR system is currently undergoing clinical trials and is designed to be consistent with the anatomy of the mitral valve, making it a safe and effective way for hospitals to treat patients with heart valve dysfunction. Their mission is to bring patients a novel therapeutic system suitable to replace incompetent Mitral Valves based on a safe, effective, and easy-to-use transcatheter technology while maintaining the highest level of quality.